1 |
Meyer, M. C. and Guttman, D. E., Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems. J. Pharm. Sci., 59, 39-48 (1970)
DOI
PUBMED
|
2 |
van Breemen. C., Hwang, O., and Meisheri, K. D., The mechanism of inhibitory action of Diltiazem on vascular smooth muscle contractibility. J. Pharmacol. Exp. Ther., 218, 459-463 (1981)
|
3 |
Terasaki, T., Nouda, H., and Tsuji, A., Relationship between lipophilicity and binding affinity with human serum albumin for penicillin and cephem antibiotics. J. Pharmacobidyn., 15, 99-106 (1992)
DOI
PUBMED
|
4 |
Ishida, S., Kinoshita, M., Sakiya, Y., Taira, Z., and Ichikawa, T., Glycyrrhizin binding site on human serum albumin. Chem. Pharm. Bull., 40, 275-278 (1992)
DOI
PUBMED
ScienceOn
|
5 |
Pacifici, G. M. and Viani, A., Methods of determining plasma and tissue binding of drugs. Clin. Pharmacakinet., 23, 449-468 (1992)
DOI
ScienceOn
|
6 |
Kiso, Y., Tohikin, M., Hikino, H., Hattori, M., Sakamoto, T., and Namba, T., Mechanism of anti hepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lip id peroxidation. Planta Med., 50, 298-302 (1984)
DOI
ScienceOn
|
7 |
Kumada, H., Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology, 62 (Suppl. 1), 94-100 (2002)
PUBMED
|
8 |
Wang, Z. Y. and Nixon, D. W., Licorice and cancer. Nutr. Cancer, 39, 1-11 (2001)
DOI
ScienceOn
|
9 |
Bowmer, C. J., Donoghue, P. G., Leong, C. F., and Yates, M. S., Effect of bile acids on the binding of drugs and dyes to human albumin. J. Pharm. Pharmacol., 37, 812-815 (1985)
DOI
|
10 |
Scatchard, G., The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci., 51, 660-672 (1949)
DOI
|
11 |
Shargel, L. and Yu, A. B. C., Physiologic drug distribution and protein binding. In Applied Biopharmaceutics and Pharmacokinetic, 4th Ed.; Appleton & Lange; Connecticut, 281-324 (1999)
|
12 |
Benet, L. Z. and Hoener. B., Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther., 71, 115-121 (2002)
DOI
ScienceOn
|
13 |
Alfonso, R., Gennaro, et al., Remington: The Science and Practice of Pharmacy, 20th Ed., Lippincott Williams & Wilkins, PA., pp. 1141-1142 (2000)
|
14 |
Ishida, S., Sakiya, Y., Ichikawa, T., Kinoshita, M., and Awazu, S., Binding of glycyrrhizin to human serum and human serum albumin. Chem. Pharm. Bull., 37, 226-228 (1989)
DOI
PUBMED
ScienceOn
|
15 |
Bean, B. P., Nitrendipine block of cardiac calcium channels: High affinity binding to the inactivated state. Proc. Natl. Acad. Sci., 81, 6388-6392 (1984)
DOI
ScienceOn
|
16 |
Hess, P., Lansman, J. B., and Tsien, R. W ., Different modes of channel gating behavior flavored by dihydropyridine Cagonists and antagonists. Nature, 311, 538-544 (1984)
DOI
ScienceOn
|
17 |
Schuhmacher, J., Buhner, K., and Witt-Laido. A., Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins. J. Pharm. Sci., 89, 1008-1021 (2000)
DOI
ScienceOn
|
18 |
Bertucci, C., Barsotti, M. C., Raffaelli, A., and Salvadori, P., Binding properties of human albumin modified by covalent binding of penicillin. Biachim. Biaphys. Acta, 1544, 386-392 (2001).
DOI
PUBMED
ScienceOn
|
19 |
Yamasaki, K., Maruyama, T., Yoshimoto, K., Tsutsumi, Y., Narazaki, R., Fukuhara, A., Kragh-Hansen, U., and Otagiri, M., Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochim. Biophys. Acta, 1432, 313-323 (1999)
DOI
PUBMED
ScienceOn
|